Lara Fallon - Publications, H-index & Citations

Lara Fallon

Pfizer

25H指数

90论文数

3.3K被引数

收录论文 25

发表时间

Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry 托法替尼在银屑病关节炎患者中单药治疗与联合治疗的疗效：来自CorEvitas银屑病关节炎/脊柱关节炎登记研究的结果

Rheumatology and Therapy

IF2.9

2025-12-04

OAAI

Alexis Ogdie; Nicole Middaugh; Taylor Blachley; Tran Bourgeois; You-Li Ling; Rajiv Mundayat; Lara Fallon; Karim R. Masri; Philip J. Mease

Population pharmacokinetics of tofacitinib in patients with active ankylosing spondylitis 托法替尼在活动性强直性脊柱炎患者中的群体药代动力学

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

IF0.7

2025-12-01

PREAI

Tsuchiwata, Shinichi; Suzuki, Akiyuki; Wang, Qiang; Kanik, Keith; Fallon, Lara; Menon, Sujatha

Tofacitinib efficacy, patient-reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2024-01-11

OAAI

Bachelez, H.; Griffiths, C. E. M.; Papp, K. A.; Hall, S.; Merola, J. F.; Feldman, S. R.; Khraishi, M.; Tan, H.; Fallon, L.; Cappelleri, J. C.; Bushmakin, A. G.; Young, P.

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE

IF4.1

2023-02-07

OAAI

Kristensen, Lars E.; Strober, Bruce; Poddubnyy, Denis; Leung, Ying-Ying; Jo, Hyejin; Kwok, Kenneth; Vranic, Ivana; Fleishaker, Dona L.; Fallon, Lara; Yndestad, Arne; Gladman, Dafna D.

Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database 托法替尼治疗银屑病关节炎的早期现实经验: 来自美国医疗保健索赔数据库的数据

ADVANCES IN THERAPY

IF4

2022-04-28

OAAI

Mease, Philip J.; Young, Pamela; Gruben, David; Fallon, Lara; Germino, Rebecca; Kavanaugh, Arthur

Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four Months

ARTHRITIS CARE & RESEARCH

IF3.3

2021-12-30

OAAI

Bykerk, Vivian P.; Lee, Eun Bong; Vollenhoven, Ronald; Gruben, David C.; Fallon, Lara; Woolcott, John C.; Keystone, Edward

Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance

LANCET RHEUMATOLOGY

IF16.4

2021-01-01

OAAI

Nash, Peter; Mease, Philip J.; Fleishaker, Dona; Wu, Joseph; Coates, Laura C.; Behrens, Frank; Gladman, Dafna D.; Kivitz, Alan J.; Wei, James C.; Shirinsky, Ivan; Menon, Sujatha; Romero, Ana B.; Fallon, Lara; Hsu, Ming-Ann; Wang, Cunshan; Kanik, Keith S.

Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire 在银屑病关节炎疾病影响 (pssaed) 问卷的背景下讨论的评估银屑病关节炎影响的全球，基于患者的调查结果

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2020-06-08

OAAI

Coates, L. C.; Orbai, A. -M.; Azevedo, V. F.; Cappelleri, J. C.; Steinberg, K.; Lippe, R.; Lim, I.; Eder, L.; Richette, P.; Weng, M. Y.; Queiro Silva, R.; Fallon, L.

Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or Adalimumab 托法替尼或阿达木单抗治疗的银屑病关节炎中根据基线C反应蛋白水平和其他危险因素的影像学进展

JOURNAL OF RHEUMATOLOGY

IF3.4

2019-03-01

OAAI

van der Heijde, Desiree; Gladman, Dafna D.; FitzGerald, Oliver; Kavanaugh, Arthur; Graham, Daniela; Wang, Cunshan; Fallon, Lara

Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report

JOURNAL OF RHEUMATOLOGY

IF3.4

2019-02-15

OAAI

Duarte-Garcia, Ali; Leung, Ying Ying; Coates, Laura C.; Beaton, Dorcas; Christensen, Robin; Craig, Ethan T.; de Wit, Maarten; Eder, Lihi; Fallon, Lara; FitzGerald, Oliver; Gladman, Dafna D.; Goel, Niti; Holland, Richard; Lindsay, Chris; Maxwell, Lara; Mease, Philip; Orbai, Ana Maria; Shea, Beverley; Strand, Vibeke; Veale, Douglas J.; Tillett, William; Ogdie, Alexis

Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6

ARTHRITIS CARE & RESEARCH

IF3.3

2018-12-27

OAAI

van Vollenhoven, Ronald F.; Lee, Eun Bong; Fallon, Lara; Zwillich, Samuel H.; Wilkinson, Bethanie; Chapman, Douglass; DeMasi, Ryan; Keystone, Edward

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials

JOURNAL OF RHEUMATOLOGY

IF3.4

2018-12-15

OAAI

Orbai, Ana-Maria; Holland, Richard; Leung, Ying Ying; Tillett, William; Goel, Niti; Christensen, Robin; McHugh, Neil; Gossec, Laure; de Wit, Maarten; Hojgaard, Pil; Coates, Laura C.; Mease, Philip J.; Birt, Julie; Fallon, Lara; FitzGerald, Oliver; Ogdie, Alexis; Shea, Beverly; Strand, Vibeke; Duffin, Kristina Callis; Tugwell, Peter; Beaton, Dorcas; Gladman, Dafna D.

Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe

RHEUMATOLOGY INTERNATIONAL

IF2.9

2018-11-13

OAAI

Gottlieb, Alice; Gratacos, Jordi; Dikranian, Ara; van Tubergen, Astrid; Fallon, Lara; Emir, Birol; Aikman, Laraine; Smith, Timothy; Chen, Linda

IMPACT OF PSORIATIC ARTHRITIS ON PATIENT-REPORTED OUTCOMES IN 5 EUROPEAN UNION COUNTRIES

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2017-06-01

OAAI

Gottlieb, A. B.; Gratacos, J.; Dikranian, A.; Fallon, L.; Emir, B.; Smith, T.; Aikman, L.; Chen, L.

PERSISTENCE OF TOFACITINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN OPEN-LABEL, LONG-TERM EXTENSION STUDIES UP TO 7 YEARS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Pope, J.; Keystone, E.; Jamal, S.; Wang, L.; Fallon, L.; Woolcott, J.; Lazariciu, I.; Haraoui, B.

LACK OF EARLY CHANGE IN DISEASE ACTIVITY SCORE PREDICTS THE LIKELIHOOD OF ACHIEVING LOW DISEASE ACTIVITY AT MONTH 6: TOFACITINIB MONOTHERAPY VERSUS METHOTREXATE IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-01

PREAI

Keystone, E.; van Vollenhoven, R. F.; Wilkinson, B.; Fallon, L.; Hwang, L. -J.; Chapman, D.; DeMasi, R.; Lee, E. B.

USING THE MEDICARE CLAIMS DATABASE TO UNDERSTAND THE ECONOMIC BURDEN OF LIVER DISEASE: A CASE STUDY IN HEPA TIC ENCEPHALOPATHY

VALUE IN HEALTH

IF6

2015-05-01

OAAI

Irish, W.; Saynisch, P.; Mallow, P. J.; Fallon, L.; Gunnarsson, C.

AUDIT OF TERTIARY HEART FAILURE OUTPATIENT SERVICE TO ASSESS COMPLIANCE WITH UPDATED NICE GUIDELINES

HEART

IF4.4

2012-05-16

OAAI

Pryse-Hawkins, H.; Davidson, L.; Fallon, L.; Guha, K.; Lyon, A. R.; Sharma, R.; Vazir, A.; Cowie, M. R.

The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability

HUMAN MOLECULAR GENETICS

IF3.2

2010-10-11

149

OAAI

Durcan, Thomas M.; Kontogiannea, Maria; Thorarinsdottir, Thorhildur; Fallon, Lara; Williams, Aislinn J.; Djarmati, Ana; Fantaneanu, Tadeu; Paulson, Henry L.; Fon, Edward A.

A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3) K-Akt signalling

NATURE CELL BIOLOGY

IF19.1

2006-07-23

367

PREAI

Fallon, Lara; Belanger, Catherine M. L.; Corera, Amadou T.; Kontogiannea, Maria; Regan-Klapisz, Elsa; Moreau, France; Voortman, Jarno; Haber, Michael; Rouleau, Genevieve; Thorarinsdottir, Thorhildur; Brice, Alexis; Henegouwen, Paul M. P. van Bergen en; Fon, Edward A.

研究方向